Tamm I - Search Results

1

Adenovirus-mediated gene transfer of P16INK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo.

Tamm I, Schumacher A, Karawajew L, Ruppert V, Arnold W, Nüssler AK, Neuhaus P, Dörken B, Wolff G. Tamm I, et al. Cancer Gene Ther. 2002 Aug;9(8):641-50. doi: 10.1038/sj.cgt.7700480. Cancer Gene Ther. 2002. PMID: 12136424

2

5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.

Schmelz K, Wagner M, Dörken B, Tamm I. Schmelz K, et al. Among authors: tamm i. Int J Cancer. 2005 May 1;114(5):683-95. doi: 10.1002/ijc.20797. Int J Cancer. 2005. PMID: 15609309

3

Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factor.

Wagner M, Schmelz K, Dörken B, Tamm I. Wagner M, et al. Among authors: tamm i. Int J Cancer. 2008 Mar 15;122(6):1278-87. doi: 10.1002/ijc.23183. Int J Cancer. 2008. PMID: 18027854

4

Apoptosis: implications of basic research for clinical oncology.

Tamm I, Schriever F, Dörken B. Tamm I, et al. Lancet Oncol. 2001 Jan;2(1):33-42. doi: 10.1016/S1470-2045(00)00193-5. Lancet Oncol. 2001. PMID: 11905616 Review.

5

High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.

Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F, Karawajew L, Ludwig WD, Wuchter C. Tamm I, et al. Clin Cancer Res. 2004 Jun 1;10(11):3737-44. doi: 10.1158/1078-0432.CCR-03-0642. Clin Cancer Res. 2004. PMID: 15173080

6

Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.

Schmelz K, Wieder T, Tamm I, Müller A, Essmann F, Geilen CC, Schulze-Osthoff K, Dörken B, Daniel PT. Schmelz K, et al. Among authors: tamm i. Oncogene. 2004 Sep 2;23(40):6743-59. doi: 10.1038/sj.onc.1207848. Oncogene. 2004. PMID: 15273737

7

In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.

Wagner M, Schmelz K, Wuchter C, Ludwig WD, Dörken B, Tamm I. Wagner M, et al. Among authors: tamm i. Int J Cancer. 2006 Sep 15;119(6):1291-7. doi: 10.1002/ijc.21995. Int J Cancer. 2006. PMID: 16619249

8

Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia.

Wagner M, Schmelz K, Dörken B, Tamm I. Wagner M, et al. Among authors: tamm i. Leuk Res. 2008 Jul;32(7):1054-60. doi: 10.1016/j.leukres.2007.11.013. Epub 2008 Feb 21. Leuk Res. 2008. PMID: 18206228

9

Antisense therapy in oncology: new hope for an old idea?

Tamm I, Dörken B, Hartmann G. Tamm I, et al. Lancet. 2001 Aug 11;358(9280):489-97. doi: 10.1016/S0140-6736(01)05629-X. Lancet. 2001. PMID: 11513935 Review.

10

XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.

Tamm I, Richter S, Scholz F, Schmelz K, Oltersdorf D, Karawajew L, Schoch C, Haferlach T, Ludwig WD, Wuchter C. Tamm I, et al. Hematol J. 2004;5(6):489-95. doi: 10.1038/sj.thj.6200549. Hematol J. 2004. PMID: 15570290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

257 results

Search Page

Filters